Key Features of SAMHSA’s Hair Testing Guidelines: A Preview Ahead of May 2025 Release

As the landscape of substance use monitoring continues to evolve, the Substance Abuse and Mental Health Services Administration (SAMHSA) is poised to make significant advancements with the forthcoming release of its hair testing guidelines in May 2025. These guidelines promise to establish a comprehensive framework for the implementation of hair testing as a reliable method for detecting substance use, thereby enhancing the efficacy of drug screening practices in various settings, including workplaces and clinical environments. By integrating scientific research and best practices, SAMHSA aims to provide a robust set of standards that address both the validity and reliability of hair testing, ensuring that it aligns with contemporary needs in drug monitoring.

This article will explore the key features of these guidelines, including methodologies for sample collection and analysis, methods for interpreting results, and considerations for maintaining confidentiality and integrity throughout the testing process. As we anticipate the impact of these guidelines, understanding their foundational elements will be crucial for stakeholders across industries who rely on accurate drug testing to promote safety, health, and ethical practices within their respective domains.

Long-Awaited Changes in Drug Testing Guidelines for Safety-Sensitive Employers

After years of anticipation, safety-sensitive employers may soon see a significant shift in drug testing procedures. The Substance Abuse and Mental Health Services Administration (SAMHSA) is set to unveil its proposed guidelines for hair testing in May 2025, a development long awaited by many in the industry. It has been a decade since the Department of Transportation (DOT) first proposed changes to drug testing protocols to the Department of Health and Human Services (HHS) in 2015, as part of the Fixing America’s Surface Transportation (FAST) Act. Although Congress mandated that HHS complete the guidelines by December 2016, progress has been sluggish. Initially, concerns regarding privacy rights and potential inaccuracies in hair testing methods delayed the approval process. Critics raised issues about environmental factors that might lead to false positives, particularly among certain ethnic groups. After addressing these concerns, other complications arose, creating a drawn-out regulatory journey that left employers waiting for clearer direction.

Initial Proposals and Industry Pushback

Five years passed before the first set of proposed guidelines was released, only for them to be retracted following considerable industry criticism. A central point of contention was a requirement for a “urine back-up test” to validate positive results from hair follicle testing. Many industry stakeholders argued that it was illogical for safety-sensitive employers to be compelled to use an outdated testing method for confirmation, rather than adhering to the established hair testing protocol. This dual-collection requirement would impose unnecessary costs on employers, particularly in sectors like transportation where compliance testing is already expensive and logistically demanding. Employers also noted that the redundancy could lead to confusion and potential inconsistencies in testing outcomes. The opposition was not merely about costs—it reflected a broader push for modernization. Industry experts insisted that testing protocols should evolve alongside science and technology rather than rely on outdated procedures that compromise efficiency and accuracy.

A Better Approach to Hair Testing

Under current urine testing procedures, the sample is divided into two portions: one for immediate testing and another reserved for potential retesting if a positive result occurs. If hair follicle testing guidelines were implemented as originally proposed, both a hair sample and a urine sample would be required, with the latter held in reserve pending the outcome of the hair test. The industry broadly contended that hair samples should be treated comparably to urine samples, eliminating the need for employers to incur costs associated with maintaining a urine back-up that would rarely be used. Collecting a urine sample alongside a hair sample complicates logistics for collectors and labs, particularly regarding storage and chain-of-custody requirements. Moreover, a driver may test positive on a hair drug test while receiving a negative urine test, given the vastly different detection windows. This discrepancy can create confusion about which result should take precedence. Compounding the issue, not all laboratories conduct testing for both hair and urine, which adds yet another layer of complexity when employers need to send specimens to different facilities.

Looking Ahead: Anticipation for SAMHSA’s Guidelines

As the trucking industry awaits the upcoming release of SAMHSA’s hair testing guidelines, there is growing optimism that finalization may be near. The ability to examine drug use over a ninety-day period could provide employers with valuable insight into habitual substance use, rather than just recent consumption. Consequently, many trucking companies are already taking proactive measures by mandating both urine and hair samples for DOT drug testing. This dual approach, while costlier, gives employers greater confidence that they are identifying and addressing potential safety risks before they impact operations. The widespread adoption of hair testing could also have a cultural effect—deterring habitual users from entering safety-sensitive positions altogether. The industry recognizes that while no method is perfect, hair testing offers a longer detection window that helps foster accountability and long-term safety.

Trends and Impacts in Testing Practices

Employers have reported that the mere prospect of hair testing can discourage some potential drivers from applying for positions, suggesting that its deterrent effect may already be working. Data from 2021 underscores this impact: among the 88,000 commercial driver’s license (CDL) holders who applied for jobs, both hair and urine samples were collected. Over 400 drivers tested positive on urine tests, while approximately 4,000 tested positive on hair tests—a tenfold increase. This stark difference between the two testing methods reveals the limitations of urine testing, which primarily detects short-term use. In contrast, hair testing exposes longer-term patterns of substance use that could otherwise remain hidden, ensuring that only safe and compliant drivers remain in service. Employers, regulators, and policymakers are closely watching these results, recognizing that hair testing could become the gold standard in safety-sensitive industries if properly implemented and standardized across the nation.

Staying Informed and Moving Forward

For those employing safety-sensitive personnel, it is crucial to stay informed as SAMHSA releases its proposed guidelines. Industry leaders are encouraged to participate in public discussions and provide feedback on the forthcoming changes, ensuring that their operational realities and compliance challenges are represented. Hair testing offers a reliable, tamper-resistant method for detecting habitual drug use, as metabolites permanently bond with the hair shaft, making falsification extremely difficult. As acceptance of hair testing grows, associated costs are likely to decline, making it an increasingly viable option for large and small employers alike. It is essential for employers and industry associations to advocate collectively for modernized, practical testing standards. Progress in this area not only strengthens workplace safety but also aligns national policies with technological advancements that promote fairness and accuracy in testing procedures.

Conclusion: A Step Toward a Safer, More Transparent Industry

The impending rollout of SAMHSA’s hair testing guidelines represents a long-overdue modernization in the realm of workplace safety and compliance. By embracing a method capable of detecting long-term substance use, the transportation and logistics industries can more effectively safeguard employees, passengers, and the public. While challenges remain—such as cost, standardization, and public perception—the benefits of hair testing are clear. Its ability to reveal patterns of use over time makes it a powerful tool for preventing accidents and fostering trust within organizations. As the industry prepares for this transition, the focus must remain on balance: protecting individual rights while ensuring collective safety. With collaboration, transparency, and technological progress, hair testing could mark the next great leap forward in creating drug-free, responsible workplaces.

READI COLLECT: Your Trusted Partner in Drug and Alcohol Testing Compliance

As the industry anticipates the upcoming SAMHSA hair testing guidelines, staying compliant and adaptable is more important than ever. READI Collect empowers safety-sensitive employers to stay ahead of regulatory changes with the fastest and most reliable mobile and onsite drug and alcohol testing services available. Through patented technology, the READI Collect App connects your company to a nationwide network of professional collectors—streamlining everything from DOT post-accident testing to routine compliance checks. With real-time reporting, rapid collector dispatch, and support for multiple testing methods (including urine, oral fluid, and hair), READI Collect ensures you’re always prepared to meet evolving DOT and HHS standards. Protect your workforce, maintain compliance, and simplify your testing process with READI Collect — where technology meets trust. 👉 Learn more or get started today: https://readicollect.com

Tags: hair testing, Department of Health and Human Services, drug testing, Substance Abuse and Mental Health Services Administration, Federal agencies, Department of Transportation, Federal Register, proposed rulemaking, Federal Motor Carrier Safety Administration, Mandatory Guidelines for Federal Workplace Drug Testing Programs, hair color, hair drug testing, FAST Act, Fixing America's Surface Transportation, urine testing, medical reasons, regulatory agenda, Drug and Alcohol Clearinghouse, Owner-Operator Independent Drivers Association, urine sample, saliva sample, federal guidelines, Hair follicle drug testing, Knight-Swift Transportation, oral fluid testing, drug testing specimen, federally approved, racial bias, executive order, Biden administration, Department of Justice, Drug Testing Advisory Board, Office of Management and Budget, Federal Mandates, hair follicle drug test, drug metabolites, delta-9-tetrahydrocannabinol-9-carboxylic acid, drug detection window, long term use, repetitive drug use, habitual drug use, lifestyle test, scientific validity, ChildGuard hair testing, Fixing America's Surface Transportation Act, commercial driver's license, CDL rule, Drug & Alcohol Clearinghouse, driver violation information, Owner-Operator Independent Drivers Associates, drug testing records, urine drug test, mouth swab, urine oral fluid, specimen validity testing, specimen guides, drug-impaired driving, background and drug screening forms, National Laboratory Certification Program, Quest Diagnostics, RTI International, Medical Review Officer, Knowledge Graph, discrimination claims, Racial & Religious Bias Allegations, religious reasons, Sikh Coalition, North American Punjabi Trucking Association, Jurisdictional turf wars, White House, Justice Department, pardon process, autopen pardons, Justice Department's Weaponization Working Group, U.S. Department of Health and Human Services, testing window, J.B. Hunt Transport, certified labs, Jones v. City of Boston, Thompson v. Civil Service Com'n, DEI Political Sensitivities